CN Patent

CN118338900A — 含尼罗加司他的组合物和治疗

Assigned to Springworths Treatment Co ltd · Expires 2024-07-12 · 2y expired

What this patent protects

本公开涉及包含尼罗加司他或其药学上可接受的盐的组合物以及治疗方法。

USPTO Abstract

本公开涉及包含尼罗加司他或其药学上可接受的盐的组合物以及治疗方法。

Drugs covered by this patent

nirogacestat-hydrobromide (NIROGACESTAT HYDROBROMIDE)

Patent Metadata

Patent number: CN118338900A
Jurisdiction: CN
Classification: —
Expires: 2024-07-12
Drug substance claim: No
Drug product claim: No
Assignee: Springworths Treatment Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.